| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.37B | 22.86B | 20.64B | 16.14B | 15.38B | 13.86B |
| Gross Profit | 5.95B | 6.50B | 5.11B | 2.92B | 2.40B | 2.76B |
| EBITDA | 1.84B | 2.57B | 1.51B | 970.38M | 442.61M | 283.37M |
| Net Income | 480.39M | 1.20B | 287.56M | 280.17M | 348.26M | 573.60M |
Balance Sheet | ||||||
| Total Assets | 15.24B | 18.42B | 15.96B | 8.22B | 7.85B | 7.26B |
| Cash, Cash Equivalents and Short-Term Investments | 5.59B | 7.07B | 6.49B | 3.12B | 2.67B | 2.00B |
| Total Debt | 50.59M | 16.88M | 67.48M | 1.06M | 8.64M | 23.25M |
| Total Liabilities | 7.11B | 9.48B | 7.88B | 4.28B | 4.16B | 3.90B |
| Stockholders Equity | 8.05B | 8.84B | 8.02B | 3.93B | 3.69B | 3.36B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.27B | 738.97M | 1.01B | 779.02M | 614.77M |
| Operating Cash Flow | 0.00 | 3.51B | 1.31B | 1.16B | 891.61M | 845.81M |
| Investing Cash Flow | 0.00 | -2.43B | -640.15M | -609.55M | -124.14M | -308.98M |
| Financing Cash Flow | 0.00 | -502.40M | -352.44M | -90.43M | -97.72M | -1.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥11.84B | 9.97 | ― | 1.84% | 10.76% | 324.17% | |
74 Outperform | ¥106.77B | 14.19 | ― | 1.71% | 5.83% | 28.78% | |
72 Outperform | ¥1.17T | 36.08 | 7.76% | 1.67% | 3.12% | 21.97% | |
72 Outperform | ¥318.28B | 11.69 | 7.48% | 1.79% | 4.76% | 15.97% | |
70 Outperform | ¥16.35B | 13.16 | ― | 3.04% | -3.59% | -29.46% | |
62 Neutral | ¥27.71B | 27.18 | ― | 2.17% | 0.48% | 103.08% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |